🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pancreatic Cancer Metastatic to Liver

Lenvatinib Plus Chemotherapy for pNET Liver Metastases NCT07835893Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Lenvatinib, Chemotherapy Advanced Therapies for Liver Metastases NCT04622423n/a1 site📍 Milan IRCCS San Raffaele IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites📍 St Louis📍 Houston📍 San Antonio ViroMissile, Inc. · Tests: IDOV-Immune (oncolytic vaccinia virus) Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors NCT06016855Phase 41 site📍 Nashville Vanderbilt-Ingram Cancer Center · Tests: Tumor Debulking, Lutetium Lu 177 Dotatate, Computed Tomography, Magnetic Resonance Imaging, Copper Cu 64 Dotatate The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study NCT04075305n/a18 sites📍 Pittsburgh📍 Houston📍 Milwaukee UMC Utrecht · Tests: Radiation therapy Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors NCT07523529Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: Autologous dual-target CAR-T cells selected from the predefined target library., Fludarabine, Cyclophosphamide Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma NCT06582017Phase 111 sites📍 Los Angeles📍 Los Angeles📍 Los Angeles Nammi Therapeutics Inc · Tests: QXL138AM Injection every 2 weeks by IV Infusion Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors NCT07191418NA1 site📍 Umeå Roberto Valente · Tests: Habib™ EndoHPB, ERCP Liver Embolization Approaches for Tumor Management NCT05714124n/a1 site📍 Milan IRCCS San Raffaele · Tests: Embolization EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470Phase 112 sites📍 Los Angeles📍 Grand Rapids📍 Lake Success MacroGenics · Tests: MGC026 Dose Escalation, MGC026 Dose for Expansion Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases NCT07504471Phase 21 site📍 Shanghai Ruijin Hospital · Tests: pH-NASOX-Immune Group PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa NCT07252076n/a1 site📍 Alessandria Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di… · Tests: Contrast-enhanced MRI and DWI sequences Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver NCT06690528Phase 21 site📍 Padova Azienda Ospedaliera di Padova · Tests: Surgical resection of both the primary tumor and liver metastases Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors NCT05040360Phase 2448 sites📍 Anchorage📍 Anchorage📍 Anchorage SWOG Cancer Research Network · Tests: Capecitabine, Temozolomide Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors NCT05732831Phase 1, Phase 226 sites📍 Palo Alto📍 Grand Junction📍 Lake Mary Tango Therapeutics, Inc. · Tests: TNG462, Pembrolizumab Stereotactic Magnetic Resonance Guided Radiation Therapy NCT04115254NA2 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: MR-guided Linac Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis NCT06307080NA1 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Multi-mode thermal ablation device, Intravenous anti-PD-1 and chemotherapy Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype NCT06753136NA1 site📍 Padova Istituto Oncologico Veneto IRCCS · Tests: percutaneous, laparoscopic or laparotomy lesion electrochemotherapy GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer NCT07627191EARLY Phase 11 site📍 Tucson University of Arizona · Tests: GLP1-RA (semaglutide) SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites📍 Birmingham📍 Mobile📍 Scottsdale Massive Bio, Inc. · Tests: Clinical Trial Matching A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors NCT06533332Phase 15 sites📍 Ryde📍 Sydney📍 Westmead EtiraRx Australia Pty Ltd · Tests: ERX-315 CREO - Microwave Ablation Feasibility Study NCT07817147NA7 sites📍 Gilbert📍 Los Angeles📍 Chicago Banner Health · Tests: EUS-Guided MWA Device High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies NCT05053555NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: high dose rate brachytherapy, high dose rate brachytherapy Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: PICO G2 4k Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial NCT05744219Phase 31 site📍 Uppsala Jon Unosson · Tests: Ferric carboxymaltose, Placebo Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery NCT05428358NA3 sites📍 Aalborg📍 Aarhus📍 Copenhagen University of Aarhus · Tests: Preoperative MRI A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors NCT06440005Phase 17 sites📍 Los Angeles📍 Sarasota📍 St Louis Angiex, Inc. · Tests: AGX101 SL-28 for Advanced Solid Tumours NCT07341737Phase 1, Phase 23 sites📍 Sydney📍 Gold Coast📍 Adelaide Second Life Therapeutics · Tests: SL-28, SL-28, SL-28
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy